FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to the field of pharmaceutics and medicine and deals with medication for treatment of polycystic kidney disease, which represents a compound of general formula (1), as well as a method of treating polycystic kidney disease by introduction of efficient amount of the compound of general formula (1) to a patient who requires it.
EFFECT: invention ensures high treatment efficiency.
13 cl, 1 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
2-ACYLAMINOPROPANOL GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | 2009 |
|
RU2578947C2 |
BRIDGED N-CYCLYC SULPHONAMIDO-INHIBITORS OF GAMMA-SECRETASE | 2006 |
|
RU2422443C2 |
PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND USE THEREOF IN PHARMACEUTICAL PREPARATIONS | 2013 |
|
RU2701156C2 |
BICYCLIC COMPOUNDS AS PD1/PD-L1 INTERACTION/ACTIVATION INHIBITORS | 2019 |
|
RU2777980C2 |
BENZYLPHENYLCYCLOHEXANE DERIVATIVES AND METHODS OF THEREOF APPLICATION | 2008 |
|
RU2505521C2 |
FGFR AND ITS MUTATION INHIBITOR, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2811207C1 |
DERIVATIVES OF 2-AMINO-1,3,5-TRIAZINE, HERBICIDE AGENT BASED ON THEREOF AND METHOD FOR CONTROL OF HAZARD PLANTS | 1999 |
|
RU2255934C2 |
DERIVATIVES OF HYDROXAMIC ACID, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL OR VETERINARY COMPOSITION BASED ON SAID | 1993 |
|
RU2126791C1 |
ANTIBACTERIAL AGENT | 2000 |
|
RU2269525C2 |
Authors
Dates
2014-05-27—Published
2008-10-03—Filed